Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help prevent the development of ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...
The new guidance from the Ovarian Cancer Research Alliance comes after the organization found that early screening and detection attempts were not effective in preventing deaths The Ovarian Cancer ...
“Knowledge is power,” says Samantha Carlucci, 26. The Ravena, New York, resident recently had a hysterectomy that included removing her fallopian tubes – and believes it saved her life. The Ovarian ...
Because there is no effective screening method to catch ovarian cancer at an early stage, most diagnoses occur when the cancer has reached its later stages. As a result, only about half of women with ...
Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, ...
NEW YORK - Ovarian cancer is the fifth leading cause of cancer death in women in the United States, according to the American Cancer Society. Some doctors have renewed calls for some women to remove ...
Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help reduce the risk of developing ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...
Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...
Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to ...
All women, regardless of their risk profile, should consider prophylactic removal of the fallopian tubes at the same time as other pelvic surgery once they are finished having children, the Ovarian ...
Please provide your email address to receive an email when new articles are posted on . Clinicians should advocate for opportunistic salpingectomy among patients undergoing surgery for benign pelvic ...
FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results